Phase 3 trial

June 4, 2018

Laser-guided Treatment Better in Long Term than Monitoring for Low-risk Prostate Cancer, New Phase 3 Data Show

News

Prostate cancer patients who undergo a nonsurgical procedure to remove part of their prostate gland — using a kind of photodynamic therapy targeting the blood vessels — fare better in ... Read more

April 4, 2018

Phase 3 Trial Testing Darolutamide in Castration-resistant Prostate Cancer Expected to Conclude in September

News

A Phase 3 clinical trial evaluating darolutamide (ODM-201) as a treatment for castration-resistant prostate cancer patients at high risk for metastasis is expected to conclude in September 2018, Orion, the therapy’s maker, announced. ... Read more

January 3, 2018January 11, 2018

Enrollment Completed for Phase 3 Trial Evaluating 1404 Radioactive Imaging Agent

News

Progenics Pharmaceuticals has completed enrollment in the Phase 3 study assessing its PSMA-targeted imaging agent 1404 as a tool to identify prostate cancer patients with clinically significant disease. “The results of this ... Read more